Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q1 2016 · 10-Q
Revenue$230.41K$230.41K−16.4% vs Q1 2015 Net Income-$528.59K-$528.59KN/M vs Q1 2015 EPS Diluted$0.00$0.00— vs Q1 2015 Operating Income-$334,656N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Free Cash Flowderived-$331,705— Margins · derivedOperating margin-145.2%−142.5 pt vs Q1 2015
Net margin-229.4%−155.7 pt vs Q1 2015
ended Mar 31, 2016 · filed May 23, 2016 · 53 d after period end